Market Research Logo

Global Viscosupplementation Market 2016-2020

About Viscosupplementation

Viscosupplementation is a minimally invasive treatment for knee osteoarthritis. It involves the injection of hyaluronic acid into a knee joint to assist the viscous properties of synovial fluid. The procedure increases the joint’s functioning and reduces pain. Intra-articular viscosupplementation with hyaluronic acid is gaining acceptance as it is a non-invasive procedure compared to knee replacement. It is categorized into three product segments –– single-injection cycle, three-injection cycle, and five-injection cycle.

Technavio’s analysts forecast the global Viscosupplementation market to grow at a CAGR of 6.23% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global Viscosupplementation market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of products in different regions.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Viscosupplementation Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Sanofi
  • Anika Therapeutics
  • Seikagaku
  • Fidia Farmaceutici
  • Ferring Pharmaceuticals
Other prominent vendors
  • Allergan
  • Contipro Biotech
  • DePuy Synthes
  • F. Hoffmann-La Roche
  • Galderma
  • HTL Biotechnology
  • Hyaltech
  • Expanscience Laboratoires
  • Lifecore Biomedical
  • Lipo Chemicals
  • Merz Aesthetics
  • Mylan
  • Nordic Drugs
  • Shandong Freda Biochem
  • Shanghai Jingfeng Pharmaceutical
  • Smith & Nephew
  • TEIJIN PHARMA
  • TRB Chemedica International
Market driver
  • Fast-growing geriatric population
  • For a full, detailed list, view our report
Market challenge
  • Threat from substitutes
  • For a full, detailed list, view our report
Market trend
  • Increasing patient preference for single-injection cycle
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Viscosupplementation Market 2016-2020

Technavio recognizes the following companies as the key players in the global Viscosupplementation market: Sanofi, Anika Therapeutics, Seikagaku, Fidia Farmaceutici, and Ferring Pharmaceuticals.

Other Prominent Vendors in the market are: Allergan, Contipro Biotech, DePuy Synthes, F. Hoffmann-La Roche, Galderma, HTL Biotechnology, Hyaltech, Expanscience Laboratoires, Lifecore Biomedical, Lipo Chemicals, Merz Aesthetics, Mylan, Nordic Drugs, Shandong Freda Biochem, Shanghai Jingfeng Pharmaceutical, Smith & Nephew, TEIJIN PHARMA, and TRB Chemedica International.

Commenting on the report, an analyst from Technavio’s team said: “The shift in consumer preference from cheaper five-injection cycle products to premium priced single-injection cycle products is a major positive trend being witnessed in the market in recent years. Despite its exorbitant cost, consumers are increasingly going for single-injection cycle viscosupplements because of shorter treatment time.”

According to the report, fast-growing geriatric population is the major driver driving growth in the market. A rising concern worldwide is the fast-growing elderly population, especially in the major countries such as Japan, South Korea, China, Germany, and the US. The geriatric people in these countries are affected by a wide range of chronic diseases such as cancer, liver, osteoarthritis, and kidney diseases.

Further, the report states that the increase in the number of substitutes for viscosupplementation is the major challenge being faced by the manufacturers in the market. NSAIDs, knee replacement devices, cyclooxygenase inhibitors, and joint arthroplasty devices are the substitutes for viscosupplements used in the treatment of knee osteoarthritis.

Companies Mentioned

Sanofi, Anika Therapeutics, Seikagaku, Fidia Farmaceutici, Ferring Pharmaceuticals, Allergan, Contipro Biotech, DePuy Synthes, F. Hoffmann-La Roche, Galderma, HTL Biotechnology, Hyaltech, Expanscience Laboratoires, Lifecore Biomedical, Lipo Chemicals, Merz Aesthetics, Mylan, Nordic Drugs, Shandong Freda Biochem, Shanghai Jingfeng Pharmaceutical, Smith & Nephew, TEIJIN PHARMA, TRB Chemedica International.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
      • Table Key countries
    • Vendor analysis
      • Table Global viscosupplementation market segmentation: Overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
      • Table Snapshot: Global viscosupplementation market
      • Table Global viscosupplementation market: Key impacting factors
      • Table Growth perspective in developed and emerging markets
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global viscosupplementation market 2015-2020 ($ billions)
      • Table Impact of various factors on global viscosupplementation market
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by products
    • Market overview
      • Table Global viscosupplementation market by product type 2015 and 2020
      • Table Global viscosupplementation market segmentation by product type 2015-2020 (% share)
      • Table Impact of product segments in global viscosupplementation market
    • Single-injection cycle market
      • Table Global single-injection cycle market 2015-2020 ($ billions)
    • Three-injection cycle market
      • Table Global three-injection cycle market 2015-2020 ($ billions)
    • Five-injection cycle market
      • Table Global five-injection cycle market 2015-2020
      • Table Global viscosupplementation market by five-injection cycle procedure 2015-2020 ($ billions)
  • Geographical segmentation
    • Market overview
      • Table Global viscosupplementation market by geography 2015 and 2020 (% share)
      • Table Global viscosupplementation market by geography 2015-2020 (% share)
      • Table Snapshot: Global viscosupplementation market by geography
    • Viscosupplementation market in Americas
      • Table Viscosupplementation market in Americas 2015-2020 ($ billions)
    • Viscosupplementation market in EMEA
      • Table Viscosupplementation market in EMEA ($ billions)
    • Viscosupplementation market in APAC
      • Table Viscosupplementation market in APAC ($ billions)
  • Market drivers
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Competitive scenario
      • Table Strategic success factor of companies
      • Table Competitive parameters in global viscosupplementation market
    • Market vendor ranking analysis 2015
      • Table Global viscosupplementation market vendor analysis 2015
  • Key vendor analysis
    • Geographic presence: Key vendor analysis
      • Table Regional analysis of key vendors
    • Sanofi
      • Table Sanofi profile
      • Table Sanofi strength analysis
      • Table Sanofi growth strategy matrix
      • Table Sanofi: Opportunity assessment
    • Anika Therapeutics
      • Table Anika Therapeutics profile
      • Table Anika Therapeutics strength analysis
      • Table Anika Therapeutics growth strategy matrix
      • Table Anika Therapeutics: Opportunity assessment
    • Seikagaku
      • Table Seikagaku profile
      • Table Seikagaku strength analysis
      • Table Seikagaku growth strategy matrix
      • Table Seikagaku: Opportunity assessment
    • Fidia Farmaceutici
      • Table Fidia Farmaceutici profile
      • Table Fidia Farmaceutici strength analysis
      • Table Fidia Farmaceutici growth strategy matrix
      • Table Fidia Farmaceutici: Opportunity assessment
    • Ferring Pharmaceuticals
      • Table Ferring Pharmaceuticals profile
      • Table Ferring Pharmaceuticals strength analysis
      • Table Ferring Pharmaceuticals growth strategy matrix
      • Table Ferring Pharmaceuticals: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report